Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 34 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 9790473

    Human Ebola virus species and compositions and methods thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  2. US 9790261

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  3. US 9782399

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  4. US 9783595

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  5. US 9782465

    Serologic correlates of protection against Bacillus anthracis infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  6. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  7. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  8. US 9775895

    HIV therapeutics and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  9. US 9771428

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  10. US 9765142

    TEM8 antibodies and their use in treatment and detection of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  11. US 9765031

    Cannabinoid receptor mediating compounds

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  12. US 9765123

    Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  13. US 9765342

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  14. US 9763444

    Compositions and methods for repelling blood-sucking and biting insects, ticks and mites

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  15. US 9764022

    Methods and compositions for inhibiting polyomavirus-associated pathology

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  16. US 9765063

    Amido compounds as RORγt modulators and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  17. US 9751931

    Hepatitis C virus neutralizing antibodies and methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  18. US 9750793

    Multifunctional oral vaccine based on chromosome recombineering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  19. US 9744226

    Attenuated Mannheimia haemolytica strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

  20. US 9738726

    HER2-specific monoclonal antibodies and conjugates thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  21. US 9738703

    Neutralizing antibodies to HIV-1 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  22. US 9730993

    Engineered anthrax lethal toxin for targeted delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  23. US 9732359

    Replication-competent adenoviral vectors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  24. US 9730941

    Methods and compositions for the inhibition of Pin1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.